199 related articles for article (PubMed ID: 32246586)
1. Biological tumor markers associated with local control after primary radiotherapy in laryngeal cancer: A systematic review.
Noordhuis MG; Kop EA; van der Vegt B; Langendijk JA; van der Laan BFAM; Schuuring E; de Bock GH
Clin Otolaryngol; 2020 Jul; 45(4):486-494. PubMed ID: 32246586
[TBL] [Abstract][Full Text] [Related]
2. Tumor proliferation, p53 expression, and apoptosis in laryngeal carcinoma: relation to the results of radiotherapy.
Lera J; Lara PC; Perez S; Cabrera JL; Santana C
Cancer; 1998 Dec; 83(12):2493-501. PubMed ID: 9874454
[TBL] [Abstract][Full Text] [Related]
3. Standardised Ki-67 proliferation index assessment in early-stage laryngeal squamous cell carcinoma in relation to local control and survival after primary radiotherapy.
Kop E; de Bock GH; Noordhuis MG; Slagter-Menkema L; van der Laan BFAM; Langendijk JA; Schuuring E; van der Vegt B
Clin Otolaryngol; 2020 Jan; 45(1):12-20. PubMed ID: 31561282
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. The relation between hypoxia and proliferation biomarkers with radiosensitivity in locally advanced laryngeal cancer.
van den Bovenkamp K; van der Vegt B; Halmos GB; Slagter-Menkema L; Langendijk JA; van Dijk BAC; Schuuring E; van der Laan BFAM
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3801-3809. PubMed ID: 37029804
[TBL] [Abstract][Full Text] [Related]
6. [Relation between epidermal growth factor receptor (EGFR) and p53 expression and radiocurability of laryngeal squamous cell cancer].
Dupla D; Fraczek M; Woźniak Z; Krecicki T
Otolaryngol Pol; 2009; 63(3):249-55. PubMed ID: 19886531
[TBL] [Abstract][Full Text] [Related]
7. Transoral laser microsurgery versus radiotherapy for T2 glottic squamous cell carcinoma: a systematic review of local control outcomes.
Warner L; Lee K; Homer JJ
Clin Otolaryngol; 2017 Jun; 42(3):629-636. PubMed ID: 27863075
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy in laryngeal carcinoma: can a panel of 13 markers predict response?
Wildeman MA; Gibcus JH; Hauptmann M; Begg AC; van Velthuysen ML; Hoebers FJ; Mastik MF; Schuuring E; van der Wal JE; van den Brekel MW
Laryngoscope; 2009 Feb; 119(2):316-22. PubMed ID: 19160427
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
10. Indications for postoperative radiotherapy in laryngeal carcinoma: a panel of tumor tissue markers for predicting locoregional recurrence in surgically treated carcinoma. A pilot study.
Marioni G; Blandamura S; Lionello M; Giacomelli L; Lovato A; Favaretto N; Breda S; Tealdo G; Guzzardo V; Ottaviano G; Staffieri A
Head Neck; 2014 Nov; 36(11):1534-40. PubMed ID: 23996283
[TBL] [Abstract][Full Text] [Related]
11. Laryngeal carcinoma prognosis after postoperative radiotherapy correlates with CD105 expression, but not with angiogenin or EGFR expression.
Marioni G; Blandamura S; Loreggian L; Koussis H; Lionello M; Giacomelli L; Fasanaro E; Lovato A; Staffieri A
Eur Arch Otorhinolaryngol; 2011 Dec; 268(12):1779-87. PubMed ID: 21842202
[TBL] [Abstract][Full Text] [Related]
12. Cyclin A and Ki-67 expression as predictors for locoregional recurrence and outcome in laryngeal cancer patients treated with surgery and postoperative radiotherapy.
Saarilahti K; Kajanti M; Kouri M; Aaltonen LM; Franssila K; Joensuu H
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):986-95. PubMed ID: 14575829
[TBL] [Abstract][Full Text] [Related]
13. BCCIP as a prognostic marker for radiotherapy of laryngeal cancer.
Rewari A; Lu H; Parikh R; Yang Q; Shen Z; Haffty BG
Radiother Oncol; 2009 Feb; 90(2):183-8. PubMed ID: 19046788
[TBL] [Abstract][Full Text] [Related]
14. Surgery-based versus radiation-based treatment strategy for a high metabolic volume laryngeal cancer.
Yabuki K; Sano D; Shiono O; Arai Y; Chiba Y; Tanabe T; Nishimura G; Takahashi M; Taguchi T; Kaneta T; Hata M; Oridate N
Laryngoscope; 2017 Apr; 127(4):862-867. PubMed ID: 27576793
[TBL] [Abstract][Full Text] [Related]
15. High pATM is Associated With Poor Local Control in Supraglottic Cancer Treated With Radiotherapy.
Bruine de Bruin L; Schuuring E; de Bock GH; Slagter-Menkema L; Mastik MF; Noordhuis MG; Langendijk JA; Kluin PM; van der Laan BFAM
Laryngoscope; 2020 Aug; 130(8):1954-1960. PubMed ID: 32275333
[TBL] [Abstract][Full Text] [Related]
16. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; de Bock GH; Langendijk JA; Kluin PM; Schuuring E; van der Laan BF; van der Wal JE
Laryngoscope; 2013 Sep; 123(9):2154-60. PubMed ID: 24167820
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer.
Warner L; Chudasama J; Kelly CG; Loughran S; McKenzie K; Wight R; Dey P
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD002027. PubMed ID: 25503538
[TBL] [Abstract][Full Text] [Related]
19. Prognostic cell biological markers in cervical cancer patients primarily treated with (chemo)radiation: a systematic review.
Noordhuis MG; Eijsink JJ; Roossink F; de Graeff P; Pras E; Schuuring E; Wisman GB; de Bock GH; van der Zee AG
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):325-34. PubMed ID: 21195874
[TBL] [Abstract][Full Text] [Related]
20. Regression after 50 Gy as a selection for therapy in advanced laryngeal cancer.
Terhaard CH; Wiggenraad RG; Hordijk GJ; Ravasz LA
Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):591-7. PubMed ID: 3138211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
